UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy

Therapeutic Advances in Medical Oncology, 2016-05, Vol.8 (3), p.230-242

2016

Link zum Volltext

Verfügbarkeit prüfen

Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma

Scientific reports, 2022-11, Vol.12 (1), p.18775-18775, Article 18775

2022

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

Hepatology (Baltimore, Md.), 2023-09, Vol.78 (3), p.758-770

2023

Link zum Volltext

Verfügbarkeit prüfen

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

Genome medicine, 2023-04, Vol.15 (1), p.27-27, Article 27

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights

Molecular oncology, 2017-09, Vol.11 (9), p.1263-1272

2017

Link zum Volltext

Verfügbarkeit prüfen

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

BMC palliative care, 2020-07, Vol.19 (1), p.103-103, Article 103

2020

Link zum Volltext

Verfügbarkeit prüfen

362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma

Journal for immunotherapy of cancer, 2021-11, Vol.9 (Suppl 2), p.A389-A389

2021

Link zum Volltext

Verfügbarkeit prüfen

A New Targeted Treatment for Patients with a Germline BRCA Mutation: Olaparib in Pancreatic Cancer

Future oncology (London, England), 2020-11, Vol.16 (33), p.2691-2700

2020

Link zum Volltext

Verfügbarkeit prüfen

Genomic profiling to provide new treatment opportunities in ampullary carcinoma

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.582-582

2023

Link zum Volltext

Verfügbarkeit prüfen

Emerging Treatment Strategies in Pancreatic Cancer

Pancreas, 2021-07, Vol.50 (6), p.773

2021

Link zum Volltext

Verfügbarkeit prüfen

New Horizons in the Treatment of Metastatic Pancreatic Cancer: A Review of the Key Biology Features and the Most Recent Advances to Treat Metastatic Pancreatic Cancer

Targeted oncology, 2018-12, Vol.13 (6), p.691-704

2018

Link zum Volltext

Verfügbarkeit prüfen

Retrospective evaluation of the value of DNA damage repair gene signature in response to platinum-based chemotherapy in advanced pancreatic ductal adenocarcinoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.4137-4137

2023

Link zum Volltext

Verfügbarkeit prüfen

ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma

Clinical cancer research, 2022-04, Vol.28 (8), p.1662-1671

2022

Link zum Volltext

Verfügbarkeit prüfen

KRAS mutation detection and cfDNA in liquid biopsy as prognostic factors in pancreatic adenocarcinoma

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e16302-e16302

2022

Link zum Volltext

Verfügbarkeit prüfen

FGFR2 fusion detection in plasma: A new era in the clinical monitoring of iCCA

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4085-4085

2022

Link zum Volltext

Verfügbarkeit prüfen

The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfalls

Expert opinion on biological therapy, 2020-01, Vol.20 (1), p.15-22

2020

Link zum Volltext

Verfügbarkeit prüfen

MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.602-602

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of NUC-1031 + cisplatin versus gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS4164-TPS4164

2021

Link zum Volltext

Verfügbarkeit prüfen

Young-onset colorectal cancer: A call for action

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10563-10563

2021

Link zum Volltext

Verfügbarkeit prüfen

Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment

Journal of gastrointestinal oncology, 2017-06, Vol.8 (3), p.405-417

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Journal of clinical oncology, 2021-01, Vol.39 (3_suppl), p.TPS351-TPS351

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(77)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ramucirumab in metastatic colorectal cancer: evidence to date and place in therapy

Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma

Phase 2 trial of bintrafusp alfa as second-line therapy for patients with locally advanced/metastatic biliary tract cancers

ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA

Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

362 Association of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio with clinical outcomes to tislelizumab monotherapy in patients with previously treated advanced hepatocellular carcinoma

A New Targeted Treatment for Patients with a Germline BRCA Mutation: Olaparib in Pancreatic Cancer

Genomic profiling to provide new treatment opportunities in ampullary carcinoma

Emerging Treatment Strategies in Pancreatic Cancer

New Horizons in the Treatment of Metastatic Pancreatic Cancer: A Review of the Key Biology Features and the Most Recent Advances to Treat Metastatic Pancreatic Cancer

Retrospective evaluation of the value of DNA damage repair gene signature in response to platinum-based chemotherapy in advanced pancreatic ductal adenocarcinoma

ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma

KRAS mutation detection and cfDNA in liquid biopsy as prognostic factors in pancreatic adenocarcinoma

FGFR2 fusion detection in plasma: A new era in the clinical monitoring of iCCA

Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters

The role of PIGF blockade in the treatment of colorectal cancer: overcoming the pitfalls

Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma

MSI exploration in patients with biliary tract cancer from the Spanish RETUD Registry

Phase III study of NUC-1031 + cisplatin versus gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Young-onset colorectal cancer: A call for action

Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment

Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241]

Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

The genomic landscape of IDH1 mutant intrahepatic cholangiocarcinoma: a multicentre comprehensive analysis

Suchergebnisse filtern